EI-001
Vitiligo, Alopecia areata, HLH
PreclinicalActive
Key Facts
Indication
Vitiligo, Alopecia areata, HLH
Phase
Preclinical
Status
Active
Company
About Elixiron Immunotherapeutics
Taiwan biotech delivering precision immunotherapies for neurodegeneration, autoimmunity, and cancer via mRNA and antibody platforms.
View full company profile